Cargando…

Blocking Type I Interferon Production: A New Therapeutic Option to Reduce the HIV-1-Induced Immune Activation

Highly active antiretroviral therapy has dramatically improved the morbidity and mortality of HIV-1-infected individuals. A total of 25 licensed drugs provide the basis for an optimized virus-suppressive treatment of nearly each subject. The promises of immune reconstitution and normal life expectan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ries, Moritz, Pritschet, Kathrin, Schmidt, Barbara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3235520/ https://www.ncbi.nlm.nih.gov/pubmed/22203858 http://dx.doi.org/10.1155/2012/534929

Ejemplares similares

Chronic Immune Activation in HIV-1 Infection Contributes to Reduced Interferon Alpha Production via Enhanced CD40:CD40 Ligand Interaction
por: Donhauser, Norbert, et al.
Publicado: (2012)

Type I interferon in HIV treatment: from antiviral drug to therapeutic target
por: Boasso, Adriano
Publicado: (2009)

Type I Interferon: Potential Therapeutic Target for Psoriasis?
por: Yao, Yihong, et al.
Publicado: (2008)

Therapeutic Options for Coronavirus Disease 2019 (COVID-19) - Modulation of Type I Interferon Response as a Promising Strategy?
por: Mary, Aurélien, et al.
Publicado: (2020)

Type I Interferon at the Interface of Antiviral Immunity and Immune Regulation: The Curious Case of HIV-1
por: Boasso, Adriano
Publicado: (2013)

Avian Metapneumovirus Subgroup C Phosphoprotein Suppresses Type I Interferon Production by Blocking Interferon Regulatory Factor 3 Nuclear Translocation
por: Hou, Lei, et al.
Publicado: (2022)

Ebola Zaire Virus Blocks Type I Interferon Production by Exploiting the Host SUMO Modification Machinery
por: Chang, Tsung-Hsien, et al.
Publicado: (2009)

Correction: Type I Interferon: Potential Therapeutic Target for Psoriasis?
por: Yao, Yihong, et al.
Publicado: (2009)

Complement Potentiates Immune Sensing of HIV-1 and Early Type I Interferon Responses
por: Posch, Wilfried, et al.
Publicado: (2021)

Therapeutic targeting of macrophages enhances chemotherapy efficacy by unleashing type I interferon response
por: Salvagno, Camilla, et al.
Publicado: (2019)

Avian Leukosis Virus Subgroup J Attenuates Type I Interferon Production Through Blocking IκB Phosphorylation
por: Lin, Wencheng, et al.
Publicado: (2018)

Reduced type I interferon production by dendritic cells and weakened antiviral immunity in patients with Wiskott-Aldrich syndrome protein deficiency
por: Lang, Philipp A., et al.
Publicado: (2013)

Translation of IRF-1 Restricts Hepatic Interleukin-7 Production to Types I and II Interferons: Implications for Hepatic Immunity
por: Rueschenbaum, Sabrina, et al.
Publicado: (2021)

Characterization of SARS-CoV-2 Evasion: Interferon Pathway and Therapeutic Options
por: Znaidia, Mariem, et al.
Publicado: (2022)

90K, an interferon-stimulated gene product, reduces the infectivity of HIV-1
por: Lodermeyer, Veronika, et al.
Publicado: (2013)

Distinct Type I Interferon Subtypes Differentially Stimulate T Cell Responses in HIV-1-Infected Individuals
por: Karakoese, Zehra, et al.
Publicado: (2022)

Type I interferons in viral control and immune regulation
por: Teijaro, John R
Publicado: (2016)

“Toll-free” pathways for production of type I interferons
por: Wang, Ling, et al.
Publicado: (2017)

The Role of Optineurin in Antiviral Type I Interferon Production
por: Outlioua, Ahmed, et al.
Publicado: (2018)

DHAV-1 Blocks the Signaling Pathway Upstream of Type I Interferon by Inhibiting the Interferon Regulatory Factor 7 Protein
por: Lai, Yalan, et al.
Publicado: (2021)

Disruption of Type I Interferon Induction by HIV Infection of T Cells
por: Sanchez, David Jesse, et al.
Publicado: (2015)

Type I Interferon Receptor on NK Cells Negatively Regulates Interferon-γ Production
por: Lee, Amanda J., et al.
Publicado: (2019)

c-FLIP-Short Reduces Type I Interferon Production and Increases Viremia with Coxsackievirus B3
por: Buskiewicz, Iwona A., et al.
Publicado: (2014)

A Novel Type-I Interferon Family, Bovine Interferon-Chi, Is Involved in Positive-Feedback Regulation of Interferon Production
por: Guo, Yongli, et al.
Publicado: (2020)

Role of novel type I interferon epsilon in mucosal immunity
por: Xi, Y, et al.
Publicado: (2012)

Type I and II Interferons in the Anti-Tumor Immune Response
por: Fenton, Sarah E., et al.
Publicado: (2021)

Production of type I interferons: plasmacytoid dendritic cells and beyond
por: Asselin-Paturel, Carine, et al.
Publicado: (2005)

Type I interferon
por: Niewold, Timothy B.
Publicado: (2020)

Type I interferon responses are impaired in latently HIV infected cells
por: Ranganath, Nischal, et al.
Publicado: (2016)

Manipulation of Type I Interferon Signaling by HIV and AIDS-Associated Viruses
por: He, Buyuan, et al.
Publicado: (2019)

Editorial: Type I and Type III Interferon Immune Responses in Asthma
por: Finotto, Susetta, et al.
Publicado: (2022)

The V Protein of Tioman Virus Is Incapable of Blocking Type I Interferon Signaling in Human Cells
por: Caignard, Grégory, et al.
Publicado: (2013)

NOG1 downregulates type I interferon production by targeting phosphorylated interferon regulatory factor 3
por: Xue, Qiao, et al.
Publicado: (2023)

Unraveling the Convoluted Biological Roles of Type I Interferons in Infection and Immunity: A Way Forward for Therapeutics and Vaccine Design
por: Wijesundara, Danushka Kumara, et al.
Publicado: (2014)

Fc gamma receptor IIa suppresses type I and III interferon production by human myeloid immune cells
por: Newling, Melissa, et al.
Publicado: (2018)

Interferon-α Is the Primary Plasma Type-I IFN in HIV-1 Infection and Correlates with Immune Activation and Disease Markers
por: Hardy, Gareth A. D., et al.
Publicado: (2013)

Genetic Lesions of Type I Interferon Signalling in Human Antiviral Immunity
por: Duncan, Christopher J.A., et al.
Publicado: (2021)

Type I interferon-mediated tumor immunity and its role in immunotherapy
por: Yu, Renren, et al.
Publicado: (2022)

Functional Exhaustion of Type I and II Interferons Production in Severe COVID-19 Patients
por: Ruetsch, Caroline, et al.
Publicado: (2021)

Type I Interferon Production Enhances Susceptibility to Listeria monocytogenes Infection
por: O'Connell, Ryan M., et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_5u4on1g5m1h8ar72neq40q39fo